Terms: = Sarcomas AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
136 results:
1. Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma.
Wei L; Meng J; Xiang D; Yang Q; Zhou Y; Xu L; Wang M; Chen J; Han Y
BMC Complement Med Ther; 2024 Jan; 24(1):67. PubMed ID: 38297292
[TBL] [Abstract] [Full Text] [Related]
2. Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and
Pang H; Wu H; Zhan Z; Wu T; Xiang M; Wang Z; Song L; Wei B
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186298
[TBL] [Abstract] [Full Text] [Related]
3. The anti-oncogenic effect of 17-DMAG via the inactivation of hsp90 and MET pathway in osteosarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Kubota Y; Tsumura H
Oncol Res; 2023; 31(5):631-643. PubMed ID: 37547755
[TBL] [Abstract] [Full Text] [Related]
4. Study on the mechanism of Shujin Tongluo granules in treating cervical spondylosis based on network pharmacology and molecular docking.
Wang Y; Tao X; Gao Y; Jin Z; Guo S; Li Z; Wang M; Zhao R; Zhou W; Wu J
Medicine (Baltimore); 2023 Jul; 102(29):e34030. PubMed ID: 37478234
[TBL] [Abstract] [Full Text] [Related]
5. A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features.
Saggioro M; D'Agostino S; Veltri G; Bacchiega M; Tombolan L; Zanon C; Gamba P; Serafin V; Muraro MG; Martin I; Pozzobon M
Sci Rep; 2023 Jun; 13(1):9444. PubMed ID: 37296184
[TBL] [Abstract] [Full Text] [Related]
6. hsp90-regulated CHIP/TRIM21/p21 Axis Involves in the Senescence of Osteosarcoma Cells.
Xu GS; Lin YN; Zeng Q; Li ZP; Xiao T; Ye YS; Li ZY; Gao X
Protein Pept Lett; 2023; 30(6):513-519. PubMed ID: 37211848
[TBL] [Abstract] [Full Text] [Related]
7. Stress-Inducible SCAND Factors Suppress the Stress Response and Are Biomarkers for Enhanced Prognosis in Cancers.
Sheta M; Yoshida K; Kanemoto H; Calderwood SK; Eguchi T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982267
[TBL] [Abstract] [Full Text] [Related]
8. Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours.
Naito Y; Nishida T; Doi T
Gastric Cancer; 2023 May; 26(3):339-351. PubMed ID: 36913072
[TBL] [Abstract] [Full Text] [Related]
9. Based on network pharmacology and bioinformatics to analyze the mechanism of action of Astragalus membranaceus in the treatment of vitiligo and COVID-19.
Wang Y; Ding M; Chi J; Wang T; Zhang Y; Li Z; Li Q
Sci Rep; 2023 Mar; 13(1):3884. PubMed ID: 36890149
[TBL] [Abstract] [Full Text] [Related]
10. Human γδ T cells induce CD8
Wang S; Li H; Chen T; Zhou H; Zhang W; Lin N; Yu X; Lou Y; Li B; Yinwang E; Wang Z; Wang K; Xue Y; Qu H; Lin P; Sun H; Teng W; Mou H; Chai X; Cai Z; Ye Z
Cancer Immunol Immunother; 2023 Jun; 72(6):1803-1821. PubMed ID: 36680568
[TBL] [Abstract] [Full Text] [Related]
11. Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel hsp90 C-terminal domain inhibitors against Ewing sarcoma.
Zajec Ž; Dernovšek J; Distel M; Gobec M; Tomašič T
Bioorg Chem; 2023 Feb; 131():106311. PubMed ID: 36495678
[TBL] [Abstract] [Full Text] [Related]
12. FOXO3a-dependent up-regulation of hsp90 alleviates cisplatin-induced apoptosis by activating FUNDC1-mediated mitophagy in hypoxic osteosarcoma cells.
Lu D; Liu R; Zhou Y; Zhang Z; Jiang X; Xu J; Su A; Hu Z
Cell Signal; 2023 Jan; 101():110500. PubMed ID: 36270475
[TBL] [Abstract] [Full Text] [Related]
13. Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma.
Fiorito E; Szybowska P; Haugsten EM; Kostas M; Øy GF; Wiedlocha A; Singh S; Nakken S; Mælandsmo GM; Fletcher JA; Meza-Zepeda LA; Wesche J
Br J Cancer; 2022 Nov; 127(11):1939-1953. PubMed ID: 36097178
[TBL] [Abstract] [Full Text] [Related]
14. In Silico Discovery and Optimisation of a Novel Structural Class of hsp90 C-Terminal Domain Inhibitors.
Zajec Ž; Dernovšek J; Gobec M; Tomašič T
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883440
[TBL] [Abstract] [Full Text] [Related]
15. Canine osteosarcoma cells exhibit basal accumulation of multiple chaperone proteins and are sensitive to small molecule inhibitors of GRP78 and heat shock protein function.
Mattos DR; Weinman MA; Wan X; Goodall CP; Serrill JD; McPhail KL; Milovancev M; Bracha S; Ishmael JE
Cell Stress Chaperones; 2022 May; 27(3):223-239. PubMed ID: 35244890
[TBL] [Abstract] [Full Text] [Related]
16. Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma.
Chen R; Guan Z; Zhong X; Zhang W; Zhang Y
Comput Math Methods Med; 2022; 2022():3197402. PubMed ID: 35069780
[TBL] [Abstract] [Full Text] [Related]
17. hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcoma.
Yao ZP; Zhu H; Shen F; Gong D
Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):380-390. PubMed ID: 34767669
[TBL] [Abstract] [Full Text] [Related]
18. TAS-116 (Pimitespib), an Oral hsp90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704).
Kawazoe A; Itahashi K; Yamamoto N; Kotani D; Kuboki Y; Taniguchi H; Harano K; Naito Y; Suzuki M; Fukutani M; Higuchi T; Ikeno T; Wakabayashi M; Sato A; Koyama S; Nishikawa H; Shitara K
Clin Cancer Res; 2021 Dec; 27(24):6709-6715. PubMed ID: 34593531
[TBL] [Abstract] [Full Text] [Related]
19. Zeylenone synergizes with cisplatin in osteosarcoma by enhancing DNA damage, apoptosis, and necrosis via the hsp90/AKT/GSK3β and Fanconi anaemia pathway.
Yang S; Xiao H; Sun Y; Cao L
Phytother Res; 2021 Oct; 35(10):5899-5918. PubMed ID: 34585447
[TBL] [Abstract] [Full Text] [Related]
20. Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues.
Lallier M; Marchandet L; Moukengue B; Charrier C; Baud'huin M; Verrecchia F; Ory B; Lamoureux F
Cells; 2021 Mar; 10(4):. PubMed ID: 33808130
[TBL] [Abstract] [Full Text] [Related]
[Next]